BioMarin Pharmaceutical
BMRN
#1907
Rank
NZ$17.75 B
Marketcap
NZ$92.44
Share price
-0.78%
Change (1 day)
-19.13%
Change (1 year)

BioMarin Pharmaceutical (BMRN) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$13.18 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's total assets are NZ$13.18 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BioMarin Pharmaceutical - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$12.39 B14.55%
2023-12-31NZ$10.81 B7.74%
2022-12-31NZ$10.04 B14.22%
2021-12-31NZ$8.79 B8.47%
2020-12-31NZ$8.10 B16.38%
2019-12-31NZ$6.96 B5.51%
2018-12-31NZ$6.60 B1.17%
2017-12-31NZ$6.52 B12.31%
2016-12-31NZ$5.80 B6.6%
2015-12-31NZ$5.44 B72.47%
2014-12-31NZ$3.15 B15.69%
2013-12-31NZ$2.73 B43.24%
2012-12-31NZ$1.90 B13.96%
2011-12-31NZ$1.67 B2.22%
2010-12-31NZ$1.63 B29.61%
2009-12-31NZ$1.26 B-19.18%
2008-12-31NZ$1.56 B46.8%
2007-12-31NZ$1.06 B61.8%
2006-12-31NZ$0.65 B130.22%
2005-12-31NZ$0.28 B-12.48%
2004-12-31NZ$0.32 B-17.21%
2003-12-31NZ$0.39 B86.57%
2002-12-31NZ$0.21 B-48.92%
2001-12-31NZ$0.41 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Ultragenyx Pharmaceutical
RARE
NZ$2.06 B-84.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ$0.15 B-98.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$0.63 B-95.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$263.67 B 1,900.35%๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
NZ$1.50 B-88.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
NZ$1.82 B-86.19%๐Ÿ‡บ๐Ÿ‡ธ USA